Stanford University’s School of Medicine researchers have come up with a relatively inexpensive cancer therapy tested on mice with transplanted mouse lymphoma in two different locations in their bodies.
Out of 90 mice, three of them had the tumor return but was minimized by a second treatment.By injecting two immune-stimulating agents directly into the first tumor that appears, the agents can travel to the next identical tumor and destroys it without customization of the patient’s immune cells or much interaction of the bodies immune system.
It works with various forms of cancer and even those that spontaneously appear. The possibility of unfavorable side effects are also very low.
One of the agents is already being used in a clinical trial on human patients with lymphoma.
